Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2026-06-30 16:49:50 ET · period of report 2026-06-26 · accession 0000897069-26-001472 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-30 16:49 | 2026-06-26 | PCSA | Yorke Justin W | Dir | M - OptEx | — | +203 | 353 | +135% | — |
| D | 2026-06-30 16:49 | 2026-06-26 | PCSA | Yorke Justin W | Dir | M - OptEx | $0.00 | -203 | 5,249 | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-26 | M | A | 203 | — | 353 | D | — | — | (F1) Distribution of time-based service award. |
| 2 | Derivative | Restricted Stock | 2026-06-26 | M | D | 203 | $0.00 | 5,249 | D | $0.00 · — to — | 203 Common Stock | (F1) Distribution of time-based service award. (F1) Distribution of time-based service award. |